Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1944 1
1945 1
1946 2
1947 5
1948 5
1949 6
1950 14
1951 19
1952 30
1953 20
1954 21
1955 19
1956 22
1957 31
1958 22
1959 27
1960 18
1961 32
1962 31
1963 21
1964 12
1965 14
1966 1
1967 1
1968 2
1969 2
1970 2
1971 4
1972 10
1973 6
1974 8
1975 16
1976 21
1977 24
1978 28
1979 108
1980 171
1981 181
1982 174
1983 238
1984 220
1985 293
1986 311
1987 329
1988 367
1989 379
1990 417
1991 467
1992 542
1993 533
1994 738
1995 939
1996 1253
1997 1424
1998 1752
1999 2216
2000 2769
2001 3249
2002 3833
2003 4433
2004 5097
2005 5404
2006 5913
2007 6539
2008 7123
2009 7797
2010 8702
2011 8960
2012 9693
2013 10087
2014 10365
2015 10768
2016 10323
2017 10237
2018 9986
2019 10156
2020 11023
2021 11703
2022 11098
2023 10291
2024 4020

Text availability

Article attribute

Article type

Publication date

Search Results

190,437 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for angiogenic
Your search for anciotenic retrieved no results
Angiogenic signaling pathways and anti-angiogenic therapy for cancer.
Liu ZL, Chen HH, Zheng LL, Sun LP, Shi L. Liu ZL, et al. Signal Transduct Target Ther. 2023 May 11;8(1):198. doi: 10.1038/s41392-023-01460-1. Signal Transduct Target Ther. 2023. PMID: 37169756 Free PMC article. Review.
Angiogenesis, the formation of new blood vessels, is a complex and dynamic process regulated by various pro- and anti-angiogenic molecules, which plays a crucial role in tumor growth, invasion, and metastasis. ...Here, we broadly summarize various signaling pathways …
Angiogenesis, the formation of new blood vessels, is a complex and dynamic process regulated by various pro- and anti-angiogenic …
Anti-Angiogenic Therapy: Current Challenges and Future Perspectives.
Lopes-Coelho F, Martins F, Pereira SA, Serpa J. Lopes-Coelho F, et al. Int J Mol Sci. 2021 Apr 5;22(7):3765. doi: 10.3390/ijms22073765. Int J Mol Sci. 2021. PMID: 33916438 Free PMC article. Review.
Most of the anti-angiogenic agents approved for cancer treatment rely on targeting vascular endothelial growth factor (VEGF) actions, as VEGF signaling is considered the main angiogenesis promotor. ...In this review, we deepened research on the molecular mechanisms …
Most of the anti-angiogenic agents approved for cancer treatment rely on targeting vascular endothelial growth factor (VEGF) actions, …
Tumorigenesis and the angiogenic switch.
Bergers G, Benjamin LE. Bergers G, et al. Nat Rev Cancer. 2003 Jun;3(6):401-10. doi: 10.1038/nrc1093. Nat Rev Cancer. 2003. PMID: 12778130 Review.
Much research is now devoted to determining the impact of angiogenesis on tumour development and progression, and the reciprocal influences of tumour products on the microvasculature. A more detailed understanding of the complex parameters that govern the interactions betw …
Much research is now devoted to determining the impact of angiogenesis on tumour development and progression, and the reciprocal infl …
Emerging applications of anti-angiogenic nanomaterials in oncotherapy.
Tang B, Ma W, Lin Y. Tang B, et al. J Control Release. 2023 Dec;364:61-78. doi: 10.1016/j.jconrel.2023.10.022. Epub 2023 Oct 27. J Control Release. 2023. PMID: 37871753 Review.
Under normal conditions, this process is delicately controlled by pro-angiogenic and anti-angiogenic factors. Tumor cells can produce plentiful pro-angiogenic molecules promoting pathological angiogenesis for uncontrollable growth. Therefore, anti-a …
Under normal conditions, this process is delicately controlled by pro-angiogenic and anti-angiogenic factors. Tumor cells can …
Angiogenic stimulation strategies in bone tissue regeneration.
Mahapatra C, Kumar P, Paul MK, Kumar A. Mahapatra C, et al. Tissue Cell. 2022 Dec;79:101908. doi: 10.1016/j.tice.2022.101908. Epub 2022 Aug 27. Tissue Cell. 2022. PMID: 36084409 Review.
Angiogenesis is essential for oxygen/nutrient supply, waste removal, endothelial/stem cell homing, and the release of mitogenic/angiogenic/osteogenic factors. Hence, the challenge lies in understanding the complex interdependence of angiogenesis with neo-bone …
Angiogenesis is essential for oxygen/nutrient supply, waste removal, endothelial/stem cell homing, and the release of mitogenic/an …
Angiogenic and osteogenic effects of flavonoids in bone regeneration.
Shanmugavadivu A, Balagangadharan K, Selvamurugan N. Shanmugavadivu A, et al. Biotechnol Bioeng. 2022 Sep;119(9):2313-2330. doi: 10.1002/bit.28162. Epub 2022 Jun 29. Biotechnol Bioeng. 2022. PMID: 35718883 Review.
Over the last decade, a number of flavonoids have been reported to have osteogenic-angiogenic potential in bone regeneration because of their excellent bioactivity, low cost, availability, and minimal in vivo toxicity. During new bone formation, the osteoinductive nature o …
Over the last decade, a number of flavonoids have been reported to have osteogenic-angiogenic potential in bone regeneration because …
Tetrac as an anti-angiogenic agent in cancer.
Schmohl KA, Nelson PJ, Spitzweg C. Schmohl KA, et al. Endocr Relat Cancer. 2019 Jun 1;26(6):R287-R304. doi: 10.1530/ERC-19-0058. Endocr Relat Cancer. 2019. PMID: 31063970 Review.
The naturally occurring T4 analogue tetrac blocks the pro-angiogenic actions of thyroid hormones at the integrin receptor, in addition to agonist-independent anti-angiogenic effects. Tetrac reduces endothelial cell proliferation, migration and tube formation through …
The naturally occurring T4 analogue tetrac blocks the pro-angiogenic actions of thyroid hormones at the integrin receptor, in additio …
Vessel co-option and resistance to anti-angiogenic therapy.
Kuczynski EA, Reynolds AR. Kuczynski EA, et al. Angiogenesis. 2020 Feb;23(1):55-74. doi: 10.1007/s10456-019-09698-6. Epub 2019 Dec 21. Angiogenesis. 2020. PMID: 31865479 Review.
Vessel co-option is a non-angiogenic mechanism of tumour vascularisation in which cancer cells utilise pre-existing blood vessels instead of inducing new blood vessel formation. ...The finding that vessel co-option is a significant mechanism of resistance to anti-angiog …
Vessel co-option is a non-angiogenic mechanism of tumour vascularisation in which cancer cells utilise pre-existing blood vessels ins …
A critical review on anti-angiogenic property of phytochemicals.
Rajasekar J, Perumal MK, Vallikannan B. Rajasekar J, et al. J Nutr Biochem. 2019 Sep;71:1-15. doi: 10.1016/j.jnutbio.2019.04.006. Epub 2019 May 3. J Nutr Biochem. 2019. PMID: 31174052 Review.
Thus, currently, the focus on anti-angiogenic therapy for treatment and prevention of diseases has gained significant attention. ...Therefore, identification of safe and cost-effective anti-angiogenic molecules is highly imperative. Over the past decades, dietary ba …
Thus, currently, the focus on anti-angiogenic therapy for treatment and prevention of diseases has gained significant attention. ...T …
Tumor angiogenesis: causes, consequences, challenges and opportunities.
Lugano R, Ramachandran M, Dimberg A. Lugano R, et al. Cell Mol Life Sci. 2020 May;77(9):1745-1770. doi: 10.1007/s00018-019-03351-7. Epub 2019 Nov 6. Cell Mol Life Sci. 2020. PMID: 31690961 Free PMC article. Review.
These processes are orchestrated by a range of secreted factors and signaling pathways and can involve participation of non-endothelial cells, such as progenitors or cancer stem cells. Anti-angiogenic therapies using either antibodies or tyrosine kinase inhibitors have bee …
These processes are orchestrated by a range of secreted factors and signaling pathways and can involve participation of non-endothelial cell …
190,437 results
You have reached the last available page of results. Please see the User Guide for more information.